中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

重视非肝硬化内脏静脉血栓的病因筛查

诸葛宇征

引用本文:
Citation:

重视非肝硬化内脏静脉血栓的病因筛查

DOI: 10.12449/JCH240101
利益冲突声明:本文不存在任何利益冲突。
详细信息
    通信作者:

    诸葛宇征, yuzheng9111963@aliyun.com (ORCID: 0000-0002-3829-5831)

Screening for the etiology of non-cirrhotic splanchnic vein thrombosis should be taken seriously in clinical practice

More Information
  • 摘要: 非肝硬化内脏静脉血栓(NC-SVT)主要包括门静脉血栓、肠系膜上静脉血栓、脾静脉血栓和肝静脉血栓(布加综合征),其患病率随着相关基础疾病发病率升高而呈现上升趋势。由于NC-SVT严重的危害性,临床医生对其诊断意识和诊断能力也明显提高。但在治疗上往往只重视抗凝、介入等针对血栓的处理,而忽视对导致SVT的危险因素或基础疾病的筛查,一定程度上影响部分患者的血栓治疗效果,也将延误对基础疾病的诊断和治疗。本文简要介绍了与NC-SVT发生相关的获得性、遗传性及系统性、局部性基础疾病。

     

  • [1] VALERIANI E, RIVA N, di NISIO M, et al. Splanchnic vein thrombosis: Current perspectives[J]. Vasc Health Risk Manag, 2019, 15: 449- 461. DOI: 10.2147/VHRM.S197732.
    [2] ELKRIEF L, PAYANCÉ A, PLESSIER A, et al. Management of splanchnic vein thrombosis[J]. JHEP Rep, 2023, 5( 4): 100667. DOI: 10.1016/j.jhepr.2022.100667.
    [3] HOW J, ZHOU A, OH ST. Splanchnic vein thrombosis in myeloproliferative neoplasms: Pathophysiology and molecular mechanisms of disease[J]. Ther Adv Hematol, 2017, 8( 3): 107- 118. DOI: 10.1177/2040620716680333.
    [4] de FRANCHIS R, BOSCH J, GARCIA-TSAO G, et al. Baveno VII-Renewing consensus in portal hypertension[J]. J Hepatol, 2022, 76( 4): 959- 974. DOI: 10.1016/j.jhep.2021.12.022.
    [5] QI X, HAN G, GUO X, et al. Review article: The aetiology of primary Budd-Chiari syndrome-differences between the West and China[J]. Aliment Pharmacol Ther, 2016, 44( 11-12): 1152- 1167. DOI: 10.1111/apt.13815.
    [6] DENNINGER MH, CHAÏT Y, CASADEVALL N, et al. Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factors[J]. Hepatology, 2000, 31( 3): 587- 591. DOI: 10.1002/hep.510310307.
    [7] HOEKSTRA J, LEEBEEK FWG, PLESSIER A, et al. Paroxysmal nocturnal hemoglobinuria in Budd-Chiari syndrome: Findings from a cohort study[J]. J Hepatol, 2009, 51( 4): 696- 706. DOI: 10.1016/j.jhep.2009.06.019.
    [8] LANE DA, BAYSTON T, OLDS RJ, et al. Antithrombin mutation database: 2nd(1997) update. for the plasma coagulation inhibitors subcommittee of the scientific and standardization committee of the international society on thrombosis and haemostasis[J]. Thromb Haemost, 1997, 77( 1): 197- 211.
    [9] PRIMIGNANI M, MANNUCCI PM. The role of thrombophilia in splanchnic vein thrombosis[J]. Semin Liver Dis, 2008, 28( 3): 293- 301. DOI: 10.1055/s-0028-1085097.
    [10] POISSON J, PLESSIER A, KILADJIAN JJ, et al. Selective testing for calreticulin gene mutations in patients with splanchnic vein thrombosis: A prospective cohort study[J]. J Hepatol, 2017, 67( 3): 501- 507. DOI: 10.1016/j.jhep.2017.04.021.
    [11] PLOMPEN EPC, VALK PJM, CHU I, et al. Somatic calreticulin mutations in patients with Budd-Chiari syndrome and portal vein thrombosis[J]. Haematologica, 2015, 100( 6): e226- e228. DOI: 10.3324/haematol.2014.120857.
    [12] MURAD SD, PLESSIER A, HERNANDEZ-GUERRA M, et al. Etiology, management, and outcome of the Budd-Chiari syndrome[J]. Ann Intern Med, 2009, 151( 3): 167- 175. DOI: 10.7326/0003-4819-151-3-200908040-00004.
    [13] SØGAARD KK, FARKAS DK, PEDERSEN L, et al. Splanchnic venous thrombosis is a marker of cancer and a prognostic factor for cancer survival[J]. Blood, 2015, 126( 8): 957- 963. DOI: 10.1182/blood-2015-03-631119.
    [14] KIM AS, KHORANA AA, MCCRAE KR. Mechanisms and biomarkers of cancer-associated thrombosis[J]. Transl Res, 2020, 225: 33- 53. DOI: 10.1016/j.trsl.2020.06.012.
    [15] KANELLOPOULOU T, ALEXOPOULOU A, THEODOSSIADES G, et al. Pylephlebitis: An overview of non-cirrhotic cases and factors related to outcome[J]. Scand J Infect Dis, 2010, 42( 11-12): 804- 811. DOI: 10.3109/00365548.2010.508464.
    [16] de STEFANO V, MARTINELLI I. Splanchnic vein thrombosis: Clinical presentation, risk factors and treatment[J]. Intern Emerg Med, 2010, 5( 6): 487- 494. DOI: 10.1007/s11739-010-0413-6.
    [17] BAIGES A, PROCOPET B, SILVA-JUNIOR G, et al. Incidence and factors predictive of recurrent thrombosis in people with non-cirrhotic portal vein thrombosis[J]. J Hepatol, 2023, 78( 1): 114- 122. DOI: 10.1016/j.jhep.2022.08.023.
  • 加载中
计量
  • 文章访问数:  159
  • HTML全文浏览量:  33
  • PDF下载量:  72
  • 被引次数: 0
出版历程
  • 收稿日期:  2023-11-22
  • 录用日期:  2023-12-17
  • 出版日期:  2024-01-23
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回